Australia's largest stock trading and investment forum Australia's #1 stock forum

I would have thought, an "anti-vaccine homeopath" would be an...

First 90 Last

Share
Profile

Follow
pseudonymX

1,814 Posts.

27/08/14

10:23

Post #: 13878730
Share

Originally posted by jantimot ↑

So, when are you going to apply some critical thinking to this desire for a compliant, non-thinking population and just consider - not accept - that if autism and a whole lot of other milder psychiatric disturbances were induced by vaccines, that that might explain the almost manic desire to have as many people as possible vaccinated to obtain the maximum effect? To produce as many non-thinkers for all those repetitive, monotonous jobs for minimal rewards and maximum profit?

Then look at the sort of people supporting the drive for more and more vaccinations, such as Bill Gates. Wow, surely he doesn't need a compliant low price labour force, does he? And these people know that this is what vaccines do, and they know that the anti-vax crowd will never really get anywhere against the combined force of infinitely funded pharma companies, government edicts and, of course, the fact that they've already mostly achieved their aim of a non-thinking population anyway. And each generation the vaccine effect becomes multiplied, hence the exponential increase in autism. One in a hundred, so they say. From 12 cases in the 1940s. As Carlin says "They don’t care about you at all… at all… AT ALL. And nobody seems to notice. Nobody seems to care. Thats what the owners count on."

Expand

I would have thought, an "anti-vaccine homeopath" would be an oxymoron. But I guess I was wrong. You learn something new everyday.
Upvote

Reply

Top Stories

HAS

Yangibana 33% complete says Hastings, as it provides clarification on funding

RSG

HotCopper reacts as Resolute Mining told to pay US$160M if it wants its CEO back

RCE

Recce scores $6.75M R&D rebate

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BIO

Biome reaches intellectual property milestone in strain development program